
ZYME Valuation
Zymeworks Inc
- Overview
- Forecast
- Valuation
- Earnings
ZYME Relative Valuation
ZYME's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ZYME is overvalued; if below, it's undervalued.
Historical Valuation
Zymeworks Inc (ZYME) is now in the Overvalued zone, suggesting that its current forward PS ratio of 10.06 is considered Overvalued compared with the five-year average of -3.14. The fair price of Zymeworks Inc (ZYME) is between 8.83 to 11.26 according to relative valuation methord. Compared to the current price of 13.33 USD , Zymeworks Inc is Overvalued By 18.43%.
Relative Value
Fair Zone
8.83-11.26
Current Price:13.33
18.43%
Overvalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
2.85
P/B
Median3y
1.81
Median5y
2.46
-7.40
FCF Yield
Median3y
-4.76
Median5y
-12.57
Competitors Valuation Multiple
The average P/S ratio for ZYME's competitors is 3.19, providing a benchmark for relative valuation. Zymeworks Inc Corp (ZYME) exhibits a P/S ratio of 10.06, which is 214.92% above the industry average. Given its robust revenue growth of 170.29%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch

OPFI
OppFi Inc
11.270
USD
+0.18%

BRDG
Bridge Investment Group Holdings Inc
10.690
USD
-0.19%

EEX
Emerald Holding Inc
5.150
USD
-1.53%

GIC
Global Industrial Co
27.530
USD
+0.66%

PRLB
Proto Labs Inc
39.110
USD
+0.96%

HY
Hyster-Yale Inc
43.800
USD
+2.19%

PNTG
Pennant Group Inc
23.350
USD
+1.08%

RDFN
Redfin Corp
0
USD
-0.36%

MSC
Studio City International Holdings Ltd
4.568
USD
0.00%

OCS
Oculis Holding AG
17.710
USD
+0.34%
FAQ

Is Zymeworks Inc (ZYME) currently overvalued or undervalued?
Zymeworks Inc (ZYME) is now in the Overvalued zone, suggesting that its current forward PS ratio of 10.06 is considered Overvalued compared with the five-year average of -3.14. The fair price of Zymeworks Inc (ZYME) is between 8.83 to 11.26 according to relative valuation methord. Compared to the current price of 13.33 USD , Zymeworks Inc is Overvalued By 18.43% .

What is Zymeworks Inc (ZYME) fair value?

How does ZYME's valuation metrics compare to the industry average?

What is the current P/B ratio for Zymeworks Inc (ZYME) as of Jul 27 2025?

What is the current FCF Yield for Zymeworks Inc (ZYME) as of Jul 27 2025?

What is the current Forward P/E ratio for Zymeworks Inc (ZYME) as of Jul 27 2025?
